CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
CURRENT ASSETS
Cash	$ 10,428	$ 96,198
Advances to Supplier
Inventory	244,467	258,781
TOTAL CURRENT ASSETS	254,895	354,979
FIXED ASSETS (net of Depreciation)	30,528	31,783
TOTAL ASSETS	285,423	386,762
CURRENT LIABILITIES
Accounts payable and accrued expenses	183,203	186,528
Notes payable	363,026	258,292
Convertible Notes Payable	891,446	876,363
PPP Loan
Derivative liabilities
TOTAL CURRENT LIABILITIES	1,437,675	1,321,183
TOTAL LIABILITIES	1,437,675	1,321,183
STOCKHOLDERS’ DEFICIENCY
Preferred Stock – Par Value of $0.001; 25,000,000 shares authorized; 1,000,000 and 0 shares issued and outstanding as of March 31, 2022 and December 31, 2021	1,000	1,000
Common Stock - Par Value of $0.001; 50,000,000 shares authorized; 51,920,387 shares issued and outstanding as of March 31, 2022 and December 31, 2021	51,921	51,921
Additional paid-in capital	1,333,567	1,333,567
Accumulated deficit	(2,538,740)	(2,320,909)
TOTAL STOCKHOLDERS’ DEFICIENCY	(1,152,252)	(934,421)
TOTAL LIABILITIES & STOCKHOLDERS’ DEFICIENCY	$ 285,423	$ 386,762

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.